医学
队列
内科学
上皮性卵巢癌
肿瘤科
生物标志物
卵巢癌
阶段(地层学)
胃肠病学
恶性肿瘤
癌症
生物化学
生物
古生物学
化学
作者
June Y. Hou,Jocelyn Chapman,Ekaterina Kalashnikova,William E. Pierson,Karen Smith‐McCune,Geovanni Pineda,Reena M. Vattakalam,Alexandra Ross,Meredith Mills,Carlos J. Suarez,Tracy C. Davis,Robert P. Edwards,M.M. Boisen,Sarah Sawyer,Hsin-Ta Wu,Scott Dashner,Vasily N. Aushev,Giby V. George,Meenakshi Malhotra,Bernhard Zimmermann
标识
DOI:10.1016/j.ygyno.2022.09.004
摘要
The presence of ctDNA post-surgically is highly prognostic of reduced recurrence-free survival. CtDNA outperformed CA-125 in identifying patients at highest risk of recurrence. These results suggest that monitoring ctDNA could be beneficial in clinical decision-making for EOC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI